HIGHLIGHTS
- who: Prognostic Value et al. from the Department of Cardio-Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China, Jiangxi have published the research: Prognostic Value and Immune Landscapes of m5C-Related lncRNAs in Lung Squamous Cell Carcinoma, in the Journal: (JOURNAL)
- what: This is the first study focused on the role of m5C-related lncRNAs in LUSC. The results showed that the high-risk patients might be more sensitive to immunotherapy, imatinib, yet resistant to erlotinib, gefitinib, and vinorelbine, indicating the model has the underlying ability to guide clinical treatment.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.